Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 ShsEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 ShsEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs

Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs

No trades
See on Supercharts

Key facts today


Analysts from HSBC, Morgan Stanley, and Truist are optimistic about Eli Lilly, with projections of Orforglipron's sales reaching up to $25 billion annually by 2032.
Eli Lilly plans to invest $27 billion to build four new manufacturing facilities in the U.S. over the next five years, with two site locations expected to be announced this quarter.
Eli Lilly's olomorasib, combined with Merck's Keytruda, received FDA breakthrough designation for treating advanced non-small cell lung cancer with KRAS G12C mutation after positive trial results.
Analyze the impactAnalyze the impact
Market capitalization
‪695.83 B‬USD
0.25USD
‪9.41 B‬USD
‪40.01 B‬USD
Beta (1Y)
0.06

About Eli Lilly and Company


CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFVYP1
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Check out other big names from the same industry as LLYD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
LLY6153506
Eli Lilly and Company 4.0% 15-OCT-2028
Yield to maturity
Maturity date
Oct 15, 2028
LLY.GV
Eli Lilly and Company 5.5% 15-MAR-2027
Yield to maturity
Maturity date
Mar 15, 2027
LLY6153403
Eli Lilly and Company 4.9% 15-OCT-2035
Yield to maturity
Maturity date
Oct 15, 2035
LLY6153502
Eli Lilly and Company 5.55% 15-OCT-2055
Yield to maturity
Maturity date
Oct 15, 2055
LLY5750405
Eli Lilly and Company 4.7% 09-FEB-2034
Yield to maturity
Maturity date
Feb 9, 2034
LLY5871803
Eli Lilly and Company 5.05% 14-AUG-2054
Yield to maturity
Maturity date
Aug 14, 2054
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
Maturity date
Jun 15, 2044
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065
Yield to maturity
Maturity date
Feb 12, 2065
LLY6003092
Eli Lilly and Company 5.1% 12-FEB-2035
Yield to maturity
Maturity date
Feb 12, 2035
LLY5750031
Eli Lilly and Company 5.0% 09-FEB-2054
Yield to maturity
Maturity date
Feb 9, 2054
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053
Yield to maturity
Maturity date
Feb 27, 2053

See all LLYD bonds